As global markets face renewed fears of economic slowdown, the Swedish market remains a focal point for investors seeking stability and reliable returns. With major indices experiencing fluctuations, dividend stocks in Sweden offer an attractive option for those looking to balance their portfolios amidst uncertainty. In times of market volatility, a good dividend stock is characterized by consistent payouts and strong financial health. This article highlights three top Swedish dividend stocks that stand out for their resilience and potential to provide steady income in September 2024.
Name | Dividend Yield | Dividend Rating |
Betsson (OM:BETS B) | 5.85% | ★★★★★☆ |
Nordea Bank Abp (OM:NDA SE) | 8.69% | ★★★★★☆ |
Zinzino (OM:ZZ B) | 3.79% | ★★★★★☆ |
HEXPOL (OM:HPOL B) | 3.72% | ★★★★★☆ |
Bredband2 i Skandinavien (OM:BRE2) | 4.31% | ★★★★★☆ |
Axfood (OM:AXFO) | 3.05% | ★★★★★☆ |
Duni (OM:DUNI) | 5.08% | ★★★★★☆ |
Skandinaviska Enskilda Banken (OM:SEB A) | 5.41% | ★★★★★☆ |
Avanza Bank Holding (OM:AZA) | 4.96% | ★★★★★☆ |
Afry (OM:AFRY) | 3.04% | ★★★★☆☆ |
Click here to see the full list of 22 stocks from our Top Swedish Dividend Stocks screener.
Let's review some notable picks from our screened stocks.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: BioGaia AB (publ) is a healthcare company that provides probiotic products worldwide and has a market cap of SEK11.71 billion.
Operations: BioGaia AB (publ) generates revenue primarily from its Pediatrics segment, which accounts for SEK1072.93 million, and its Adult Health segment, contributing SEK288.68 million.
Dividend Yield: 6%
BioGaia's dividend yield of 5.96% places it in the top 25% of Swedish dividend payers, but its high cash payout ratio (193.8%) raises sustainability concerns as dividends are not well covered by free cash flows. Despite a reasonably low payout ratio (47.8%) suggesting coverage by earnings, significant insider selling over the past three months and historically volatile dividends add to the uncertainty. Recent earnings showed growth with Q2 sales at SEK 384.12 million and net income at SEK 111.01 million, indicating potential stability moving forward.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Bulten AB (publ) manufactures and distributes fasteners and related services for various industries, including automotive and consumer electronics, with a market cap of approximately SEK1.51 billion.
Operations: Bulten AB (publ) generates SEK5.95 billion in revenue from its fasteners and related services across various industries, including light vehicles, heavy commercial vehicles, automotive suppliers, consumer electronics, and more.
Dividend Yield: 3.5%
Bulten's dividend payments are covered by earnings (57% payout ratio) and cash flows (30.9% cash payout ratio), but its track record is volatile and unreliable over the past decade. Recent earnings show Q2 sales at SEK 1.47 billion with net income of SEK 34 million, a slight drop from last year. The appointment of Axel Berntsson as CEO may bring new strategic direction, potentially impacting future dividends positively or negatively.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: HEXPOL AB (publ) develops, manufactures, and sells polymer compounds and engineered products across Sweden, Europe, the Americas, and Asia with a market cap of SEK37.06 billion.
Operations: HEXPOL AB (publ) generates revenue primarily from its HEXPOL Compounding segment, which contributed SEK20.18 billion, and its HEXPOL Engineered Products segment, which added SEK1.61 billion.
Dividend Yield: 3.7%
HEXPOL's dividend payments are covered by earnings (55.4% payout ratio) and cash flows (57.8% cash payout ratio). Despite a slight decline in Q2 2024 results, with sales at SEK 5.45 billion and net income of SEK 654 million, the company maintains a reliable and growing dividend over the past decade. The recent appointment of Klas Dahlberg as CEO could influence future strategic decisions impacting dividends.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OM:BIOG B OM:BULTEN and OM:HPOL B.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。